{"name":"IMMUNOe Research Centers","slug":"immunoe-research-centers","ticker":"","exchange":"","domain":"","description":"IMMUNOe Research Centers is a biotechnology company focused on the development and commercialization of innovative therapies, particularly in the area of immunology. The company's lead product is a recombinant C1-esterase inhibitor (C1-INH-R), which has been approved for the treatment of hereditary angioedema.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE94RzZZRGdJOVJ5MktMQ1VwU2cteW5xZV9LOWIxUzRvUlZLb1RwM2Z0WV82UVBBX05pUi1EWGxybFpxTUYtU0xuNElZTDloc25aYUN0cmNJbjA2UUdOWHdn?oc=5","date":"2026-01-13","type":"trial","source":"Nature","summary":"Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trial - Nature","headline":"Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOMm5hY1JNOVYydlhsSnU3VlJfUVlveHc5bkJOcjRub3QxZ0tWLVlWOFVIUVdjMmcxcHJhLVJtUk5yTDBJbWVKTjhFNUFBNnBORkt1elpHamE1aExoTVkzcUIyZkRaV1FqVXQ4Y2tUd1hlM2o1QW5kWXZOamc3WW9PaDN0NS1PVFpJUUVWeEFlenJaS3dRd1EzUVd6Ul9TYzRhZFIw?oc=5","date":"2026-01-06","type":"pipeline","source":"University of Houston","summary":"UH Pharmacy Researcher Awarded $900K CPRIT Grant for Cancer Nanodrug - University of Houston","headline":"UH Pharmacy Researcher Awarded $900K CPRIT Grant for Cancer Nanodrug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxNbkYxYlpDQXdvWGxFU3hlSmFPNlVELUNxaFcxOUh5UkRfWUxWZnNRSU9uRlNyeExxa3ZKbjFwZjdKYU05YU1FbjQ4enMxUDVoOTB3VlVBczRjUTZhRzJsNlc1alRIUFRqUHVPbHJYTEpUdE8wQV9UTndiaHNBdm1QWjFYNm56NmtwcUR6OXptcHhFSjRieDQxNkliSzI4MFFJaVI1ZmEtX3AtUWlleWxkWkVtTkpuMXo0THJyR2xOdXJoYlpiQXZyT2ZpSktCdm1wcUZRYnN0VVVQeGlHTmZUOQ?oc=5","date":"2025-12-15","type":"deal","source":"Reuters","summary":"Adaptive signs deal with Pfizer worth up to $890 million for rheumatoid arthritis research - Reuters","headline":"Adaptive signs deal with Pfizer worth up to $890 million for rheumatoid arthritis research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNLXBISE5GSFVSU0J3LXdlTUpVcmZsb1gtcU1MRFlCSW81UUVRNUMtaWVqVV9ESTJuYXJGYXg4SjZDY0Fsa01waU53bUZkYUJsZUJ5eVFZc3I3bVRQejBJQXIxaVRZWFMyVmx2ZHRyZy1HQnJqa1dVeW1HSzFkV3NzN2ZkeXkyWGZ6WnJtUElyWnRQUm1tS1Zpb1Ryc3dnRnN1NGJNRmdINU1WTnJpcjRQUkk0U1FWMFRYcmR2bkhIMnVnUQ?oc=5","date":"2025-11-13","type":"pipeline","source":"PBS","summary":"Scientists explore new frontier in autoimmune disease treatment by resetting 'rogue' cells - PBS","headline":"Scientists explore new frontier in autoimmune disease treatment by resetting 'rogue' cells","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOTng1R3ZVUktZVExLMzBSOEU3V1RfSWoyVU9YTWlDRGp1Y0piMWJIN1pNVVZqQS1uVG8zOU8tY0hid2dvbW1LWDNSZ1FYb1JMZ2dGZ3dzUDlnMksxVVpoNmFMZ0dseGt0amR1VGc5ZWg1akRlU285S0xLX2hUdTMzTjJpQXdHaWVlQ3VIMjVqTzJXaDZRNFJoT1RJdndQcGdvb1dHZ2xMS0Q?oc=5","date":"2025-10-15","type":"pipeline","source":"Newsroom | UCLA","summary":"Gene therapy delivers lasting immune protection in children with rare disorder - Newsroom | UCLA","headline":"Gene therapy delivers lasting immune protection in children with rare disorder - Newsroom | UCLA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE4tV0ZsSENDd1BjR1haZUR4WXZnOTMxZ1VoRXdkeVZZRFRPWnA1SDA0cGt6OUVaV1dRRUdUQndOVU4wSG5Za0NHZUZZUjZTTlhTMFdXc0dlX3ByWjVsV29kQU1JaVlRUjl2TEpF?oc=5","date":"2025-10-11","type":"pipeline","source":"Wiley Online Library","summary":"Immune Surveillance and Immune Escape in Cancer: Mechanisms and Immunotherapy - Peng - 2025 - MedComm - Wiley Online Library","headline":"Immune Surveillance and Immune Escape in Cancer: Mechanisms and Immunotherapy - Peng - 2025 - MedComm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE5heUFWVk9NZDlNeXNkOS1DakFIelgtN3NwQ01aaFZSTGVjejE2MU8wbTVlUmtFdl9Bd0tqTHNXNDBkcldzWGxWbkU4Y0lydG42Z0NjVTlfMnpVZEswMFZjalBnQzZBazU2U0dvbHhkbUdOeGVRNngyZ2FpeE9mYjQ?oc=5","date":"2025-10-07","type":"regulatory","source":"chugai-pharm.co.jp","summary":"Creating and Expanding Regulatory T cells: The Possibility of Cellular Therapy Explored by a Joint Research Team from Chugai and the Immunology Frontier Research Center (IFReC), the University of Osak","headline":"Creating and Expanding Regulatory T cells: The Possibility of Cellular Therapy Explored by a Joint Research Team from Ch","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE9CMjVidmd1VEw2QUQxWWdSanFsS1J4YnFtdVNJWDd1dXdJWVdneXBGcGZGMzJyR3lvQmlMNjhkWTNXNG1sSV80QW4wS2w3dUZjVmZDQUpnaUtlYTh0WHlFQzhIMXFqazJBdWNDX01mNXVKYzZyTU9z?oc=5","date":"2025-10-06","type":"pipeline","source":"NobelPrize.org","summary":"Nobel Prize in Physiology or Medicine 2025 - Popular information - NobelPrize.org","headline":"Nobel Prize in Physiology or Medicine 2025 - Popular information","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQdy1yQ3gwS0FZU1dPTXN5UzRQTU45OE5lall2eWNWVDFPQ3c0TEo5M2NnVzJXVnRiNVJlcktXR190MGxvUVlwb2d5MEU4R0tzUWpnVzJDWUhvLWRPTzYwUURSaTltU213Rm9QQ2hGVkU1MW9YNXVYeS1sZWJNcFR3bEROSHo5YmhBdjM2VmNNUTB5cWxsRmdqODVxS05xdWRXVnZOTXpGeXJ1aUtxRWF2VHBuM29mSWN3?oc=5","date":"2025-10-06","type":"pipeline","source":"NPR","summary":"The medicine Nobel Prize goes to 3 scientists for work on peripheral immune tolerance - NPR","headline":"The medicine Nobel Prize goes to 3 scientists for work on peripheral immune tolerance","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTFBPWEtSQjRTamR3NGFLcS1abDlSQjlpVzJkSzlSN2xqdnZQVmFUYWtxUGp4em40eTZJQm1YaWRGbUJVS1hSdU42cVRlRTRsRzVQN2N5WFVVZXozUFNrc1ZrMUx6bXVZcmtrVzRNT0c4RQ?oc=5","date":"2025-09-22","type":"pipeline","source":"ScienceDaily","summary":"A hormone that silences the immune system may unlock new cancer treatments - ScienceDaily","headline":"A hormone that silences the immune system may unlock new cancer treatments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQc3hhcE1pM0NjcnVvUGxhajMtZ19mYjdXY3hDbWdxMVBHNnI2aUlIZHhodzYycmZDZlZ4M0JEVnFLTkd2dmMwREg1SUVLNmt5VnVsYUZxRGlsVjVWT2hfQWY4T2s3ZlV0TGFvMFFZMjVJSWJveV9nOC1EWXh4LTB6RHp1c1R0Q3FnY1BnaUJBS2ExNklHTE91QmQ0RlF3VnpycnV2X3FCRlZQT0psUGc3S3o1UVRMMGIwUzdTR2UyNG9oNWswVGFuaEQyeld0MExTc1Rrb29iTlM?oc=5","date":"2025-07-15","type":"pipeline","source":"BioPharma APAC","summary":"Illimis Therapeutics Raises Series B to Advance GAIA Platform for Alzheimer’s and Immune Disorders - BioPharma APAC","headline":"Illimis Therapeutics Raises Series B to Advance GAIA Platform for Alzheimer’s and Immune Disorders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQTVpITk9wa3V4Q3E3bFZuWEFvdkxUbHpuWm5iZGZ2SWhBUVRiLVNGdHFQZHJid0lzTlRMUndMOTZpM0l3T0pvRi1NaWh6N1VIMjJ3R0EtZlhXNmR5c0pHazBWdmNHV2hTd283YVNLWjQ4TkQ2cU0tMkVQT2lXbThiZkVXcWpMM00?oc=5","date":"2025-06-05","type":"pipeline","source":"National Institutes of Health (.gov)","summary":"Immune System - National Institutes of Health (.gov)","headline":"Immune System - National Institutes of Health (.gov)","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}